title: [Reculatory fragments of collagen in gastric mucosa homeostasis].
abstract: The new glyproline family was distinguished from the regulatory peptides recently. It includes the simplest proline- and glycine-containing peptides: PG, GP, PGP, and respective peptides with hydroxylated proline residues. Glyproline's bioactivity covers many important systems of the body including suppression of some reaction in the blood coagulation and platelet aggregation and gastric mucosal maintenance. It was shown that PGP, PG and GP have a wide spectrum of antiulcer activity with respect to gastric mucosal damages of various aetiology. GHyp and HypGP show also antiulcer action. In vivo glyprolines being fragments of collagen may be generated during synthesis and catabolism of collagen. It is well known that approximately 10-60% of newly synthesized collagen degrade intracellularly with succeeding secretion of small peptides composed of less than 5 aminoacid residues out of cells. Different simplest proline and hydroxyproline fragments of glyprolines are revealed in various type of collagen: GP, GHyp, PG, PPG, PGP, PHypG., GPHyp, GPP, GPG, GHypP, HypGP. It is possible that these fragments may be also secreted out of cells during the stage of degradation of newly synthesized collagen. We showed that the intragastric (per oral) introduction of hydrolyzed gelatin, having 20 small peptide fragments, including PGP and HypGP, also increase gastric stability showing protective and therapeutic antiulcer effect. The corresponding receptors for glyprolines are not completely identified yet but it may be supposed that PGP, GP and other glyprolines interact with the same receptors with which the III type collagen is binding with platelet's receptors. It is supposed that octapeptide sequence KPGGluPGPK of collagen is rather important for binding with receptor. When this sequence in the structure of collagen's molecule binds with the receptor, platelet aggregation is induced. Free octapeptide blocks the receptor and inhibits platelet aggregations. Qualitatve characteristics of parameters of inhibition with intact octapeptide and glyproline, as well as the receptor's structure--that's our concern for the nearest future.
authors.forename: I P
authors.initials: IP
authors.lastname: Ashmarin
authors.forename: G E
authors.initials: GE
authors.lastname: Samonina
authors.forename: K E
authors.initials: KE
authors.lastname: Badmaeva
authors.forename: Z V
authors.initials: ZV
authors.lastname: Bakaeva
authors.forename: B V
authors.initials: BV
authors.lastname: Vas'kovskiĭ
authors.forename: Iu A
authors.initials: IuA
authors.lastname: Zolotarev
mesh_terms: D000818:Animals; D003094:Collagen / Q000378:metabolism*; D005753:Gastric Mucosa / Q000378:metabolism / Q000502:physiology*; D005998:Glycine / Q000378:metabolism; D006706:Homeostasis / Q000502:physiology*; D006801:Humans; D006909:Hydroxyproline / Q000378:metabolism; D010446:Peptide Fragments / Q000378:metabolism*; D011392:Proline / Q000378:metabolism
chemical_list: D010446:Peptide Fragments; D003094:Collagen; D011392:Proline; D006909:Hydroxyproline; D005998:Glycine